{"transactions":[{"id":749456,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2026-06-04T22:30:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":35000,"derivative":{"exercise_price":8.77,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001193125-26-257896","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526257896/ownership.xml","form_type":"4"}},{"id":754848,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":754847,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":2026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":2026,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2026},"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":754846,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026."}],"balance_after":12158,"derivative":{"exercise_price":48.38,"expiration_date":"2036-05-28","underlying":"Class A Ordinary Shares","underlying_shares":12158},"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":754845,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2026-06-02T20:46:38.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":2799,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":15345,"source":{"system":"sec-edgar","filing":"0001403322-26-000002","document":"form4-06022026_080631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000140332226000002/form4-06022026_080631.xml","form_type":"4"}},{"id":832274,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T13:00:03.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.12,"expiration_date":"2026-05-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-116834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526116834/ownership.xml","form_type":"4"}},{"id":832273,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T13:00:03.000Z","date":"2026-03-18","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.12,"value":31200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents stock options exercised."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001193125-26-116834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000119312526116834/ownership.xml","form_type":"4"}},{"id":1066501,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":26236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.19,"expiration_date":"2033-06-04","underlying":"Class A Ordinary Shares","underlying_shares":26236},"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066500,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":33237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.33,"expiration_date":"2031-06-28","underlying":"Class A Ordinary Shares","underlying_shares":33237},"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066499,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":false,"shares":18760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Ordinary Shares","underlying_shares":18760},"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066498,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.88,"expiration_date":"2032-06-28","underlying":"Class A Ordinary Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066497,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":false,"shares":20129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.36,"expiration_date":"2028-02-29","underlying":"Class A Ordinary Shares","underlying_shares":20129},"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066496,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":27448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.8,"expiration_date":"2027-06-28","underlying":"Class A Ordinary Shares","underlying_shares":27448},"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066495,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":false,"shares":21959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.86,"expiration_date":"2026-12-06","underlying":"Class A Ordinary Shares","underlying_shares":21959},"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066494,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-14","kind":"sale","planned":false,"acquired":false,"shares":78233,"price":33.09,"value":2588729.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.82 and $33.41. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066493,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":true,"shares":26236,"price":15.19,"value":398524.84,"ownership":{"direct":true},"balance_after":90779,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066492,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":true,"shares":33237,"price":14.33,"value":476286.21,"ownership":{"direct":true},"balance_after":64543,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066491,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-14","kind":"exercise","planned":false,"acquired":true,"shares":18760,"price":15.47,"value":290217.2,"ownership":{"direct":true},"balance_after":31306,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066490,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":50129,"price":33.32,"value":1670298.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $33.1301 and $33.50. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066489,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":9.88,"value":296400.0,"ownership":{"direct":true},"balance_after":62675,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066488,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-13","kind":"exercise","planned":false,"acquired":true,"shares":20129,"price":10.36,"value":208536.44,"ownership":{"direct":true},"balance_after":32675,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066487,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":49407,"price":32.4,"value":1600786.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.06 and $32.685. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066486,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":27448,"price":3.8,"value":104302.4,"ownership":{"direct":true},"balance_after":61953,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1066485,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-08-14T20:59:03.000Z","date":"2025-08-12","kind":"exercise","planned":false,"acquired":true,"shares":21959,"price":1.86,"value":40843.74,"ownership":{"direct":true},"balance_after":34505,"source":{"system":"sec-edgar","filing":"0001415889-25-021941","document":"form4-08142025_080859.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925021941/form4-08142025_080859.xml","form_type":"4"}},{"id":1119466,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-06-06T20:05:08.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":28500,"derivative":{"exercise_price":6.57,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0000950170-25-083036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017025083036/ownership.xml","form_type":"4"}},{"id":1121411,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T21:02:16.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":false,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-25-015796","document":"form4-06052025_090659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015796/form4-06052025_090659.xml","form_type":"4"}},{"id":1121410,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2025-06-05T21:02:16.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":2799,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":2799,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":2799},"source":{"system":"sec-edgar","filing":"0001415889-25-015796","document":"form4-06052025_090659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015796/form4-06052025_090659.xml","form_type":"4"}},{"id":1121409,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2025-06-05T21:02:16.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":16798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025."}],"balance_after":16798,"derivative":{"exercise_price":29.11,"expiration_date":"2035-06-02","underlying":"Class A Ordinary Shares","underlying_shares":16798},"source":{"system":"sec-edgar","filing":"0001415889-25-015796","document":"form4-06052025_090659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015796/form4-06052025_090659.xml","form_type":"4"}},{"id":1121408,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-06-05T21:02:16.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":true,"shares":3173,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."}],"balance_after":12546,"source":{"system":"sec-edgar","filing":"0001415889-25-015796","document":"form4-06052025_090659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588925015796/form4-06052025_090659.xml","form_type":"4"}},{"id":1486896,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:39:03.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":false,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vested in a single installment on June 6, 2024; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-24-016002","document":"form4-06072024_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016002/form4-06072024_080658.xml","form_type":"4"}},{"id":1486895,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2024-06-07T20:39:03.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":3173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest in their entirety on the first anniversary date of the grant, June 5, 2024."}],"balance_after":3173,"derivative":{"underlying":"Class A Common Shares","underlying_shares":3173},"source":{"system":"sec-edgar","filing":"0001415889-24-016002","document":"form4-06072024_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016002/form4-06072024_080658.xml","form_type":"4"}},{"id":1486894,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2024-06-07T20:39:03.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":19040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 5, 2024."}],"balance_after":19040,"derivative":{"exercise_price":19.71,"expiration_date":"2034-06-04","underlying":"Class A Common Shares","underlying_shares":19040},"source":{"system":"sec-edgar","filing":"0001415889-24-016002","document":"form4-06072024_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016002/form4-06072024_080658.xml","form_type":"4"}},{"id":1486893,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Shares","published_at":"2024-06-07T20:39:03.000Z","date":"2024-06-06","kind":"exercise","planned":false,"acquired":true,"shares":4373,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":9373,"source":{"system":"sec-edgar","filing":"0001415889-24-016002","document":"form4-06072024_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588924016002/form4-06072024_080658.xml","form_type":"4"}},{"id":1486604,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-06-07T20:30:04.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":26000,"derivative":{"exercise_price":21.79,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0000950170-24-070698","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000095017024070698/ownership.xml","form_type":"4"}},{"id":1839771,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-07-03T20:15:18.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested in a single installment on June 29, 2023; there was no expiration date for the RSUs."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-23-010564","document":"form4-07032023_040714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010564/form4-07032023_040714.xml","form_type":"4"}},{"id":1839770,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Shares","published_at":"2023-07-03T20:15:18.000Z","date":"2023-06-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-23-010564","document":"form4-07032023_040714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923010564/form4-07032023_040714.xml","form_type":"4"}},{"id":1847712,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-06-21T20:29:43.000Z","date":"2023-06-16","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":11.5,"value":575000.0,"ownership":{"direct":false,"nature":"By Mossrock Capital, LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Malley serves as President of Mossrock Capital, LLC and has sole voting and investment power over these shares."}],"balance_after":139557,"source":{"system":"sec-edgar","filing":"0001209191-23-038797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123038797/doc4.xml","form_type":"4"}},{"id":1849321,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-06-20T23:00:29.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":26975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":26975,"derivative":{"exercise_price":16.41,"expiration_date":"2033-06-14","underlying":"Ordinary Shares","underlying_shares":26975},"source":{"system":"sec-edgar","filing":"0001651308-23-000097","document":"wf-form4_168730201626632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130823000097/wf-form4_168730201626632.xml","form_type":"4"}},{"id":1849320,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-20T23:00:29.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":46696,"source":{"system":"sec-edgar","filing":"0001651308-23-000097","document":"wf-form4_168730201626632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130823000097/wf-form4_168730201626632.xml","form_type":"4"}},{"id":1862473,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2023-06-08T20:23:05.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":4373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of the grant, June 6, 2023."}],"balance_after":4373,"derivative":{"underlying":"Class A Common Shares","underlying_shares":4373},"source":{"system":"sec-edgar","filing":"0001415889-23-009430","document":"form4-06082023_080600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009430/form4-06082023_080600.xml","form_type":"4"}},{"id":1862472,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2023-06-08T20:23:05.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":26236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant. The date of the grant is June 6, 2023."}],"balance_after":26236,"derivative":{"exercise_price":15.19,"expiration_date":"2033-06-05","underlying":"Class A Common Shares","underlying_shares":26236},"source":{"system":"sec-edgar","filing":"0001415889-23-009430","document":"form4-06082023_080600.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588923009430/form4-06082023_080600.xml","form_type":"4"}},{"id":1869495,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-06-02T20:53:09.000Z","date":"2023-05-31","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":26000,"derivative":{"exercise_price":13.32,"expiration_date":"2033-05-30","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001209191-23-033859","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919123033859/doc4.xml","form_type":"4"}},{"id":2218737,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-30T20:20:24.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in their entirety on the first anniversary of the date of grant, June 29, 2022."}],"balance_after":5000,"derivative":{"underlying":"Class A Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-22-007106","document":"form4-06302022_010614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007106/form4-06302022_010614.xml","form_type":"4"}},{"id":2218736,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2022-06-30T20:20:24.000Z","date":"2022-06-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2022."}],"balance_after":30000,"derivative":{"exercise_price":9.88,"expiration_date":"2032-06-28","underlying":"Class A Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001415889-22-007106","document":"form4-06302022_010614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000141588922007106/form4-06302022_010614.xml","form_type":"4"}},{"id":2221950,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-06-24T21:37:21.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":34645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":34645,"derivative":{"exercise_price":11.98,"expiration_date":"2032-06-21","underlying":"Ordinary Shares","underlying_shares":34645},"source":{"system":"sec-edgar","filing":"0001651308-22-000104","document":"wf-form4_165610662726306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130822000104/wf-form4_165610662726306.xml","form_type":"4"}},{"id":2221949,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-06-24T21:37:21.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":16692,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share unites were granted under the Company's Independent Director Compensation Policy, as amended."}],"balance_after":33774,"source":{"system":"sec-edgar","filing":"0001651308-22-000104","document":"wf-form4_165610662726306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130822000104/wf-form4_165610662726306.xml","form_type":"4"}},{"id":2222962,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2022-06-23T20:46:28.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":14.84,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-22-038917","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919122038917/doc4.xml","form_type":"4"}},{"id":2650182,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2021-06-30T20:21:35.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":33237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 29, 2021."}],"balance_after":33237,"derivative":{"exercise_price":14.33,"expiration_date":"2031-06-28","underlying":"Class A Common Shares","underlying_shares":33237},"source":{"system":"sec-edgar","filing":"0001179110-21-007184","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911021007184/edgar.xml","form_type":"4"}},{"id":2657003,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-06-23T21:16:36.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":21.54,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-21-042782","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919121042782/doc4.xml","form_type":"4"}},{"id":2660716,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2021-06-21T20:37:16.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":17498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":17498,"derivative":{"exercise_price":26.53,"expiration_date":"2031-06-15","underlying":"Ordinary Shares","underlying_shares":17498},"source":{"system":"sec-edgar","filing":"0001651308-21-000121","document":"wf-form4_162430781053430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130821000121/wf-form4_162430781053430.xml","form_type":"4"}},{"id":2660715,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-21T20:37:16.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":17082,"source":{"system":"sec-edgar","filing":"0001651308-21-000121","document":"wf-form4_162430781053430.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130821000121/wf-form4_162430781053430.xml","form_type":"4"}},{"id":3092286,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2020-07-02T20:12:02.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":18760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is June 30, 2020."}],"balance_after":18760,"derivative":{"exercise_price":25.48,"expiration_date":"2030-06-29","underlying":"Class A Common Shares","underlying_shares":18760},"source":{"system":"sec-edgar","filing":"0001104659-20-080549","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465920080549/a4.xml","form_type":"4"}},{"id":3098414,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-26T20:08:07.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":17.97,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-20-039070","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919120039070/doc4.xml","form_type":"4"}},{"id":3104160,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2020-06-19T20:17:13.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":45383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":45383,"derivative":{"exercise_price":13.42,"expiration_date":"2030-06-16","underlying":"Ordinary Shares","underlying_shares":45383},"source":{"system":"sec-edgar","filing":"0001651308-20-000078","document":"wf-form4_159259781429439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130820000078/wf-form4_159259781429439.xml","form_type":"4"}},{"id":3476848,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2019-06-27T20:07:49.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":13000,"derivative":{"exercise_price":19.55,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-19-039242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919119039242/doc4.xml","form_type":"4"}},{"id":3497033,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2019-06-07T20:07:16.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":64610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares."}],"balance_after":64610,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":64610},"source":{"system":"sec-edgar","filing":"0001651308-19-000054","document":"wf-form4_155993800860144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000165130819000054/wf-form4_155993800860144.xml","form_type":"4"}},{"id":3507680,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option","published_at":"2019-05-30T22:33:08.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":18760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of grant. The date of grant is May 29, 2019."}],"balance_after":18760,"derivative":{"exercise_price":15.47,"expiration_date":"2029-05-28","underlying":"Class A Common Shares","underlying_shares":18760},"source":{"system":"sec-edgar","filing":"0001179110-19-006868","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000117911019006868/edgar.xml","form_type":"4"}},{"id":3900169,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2018-06-08T21:50:01.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":17442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares."}],"balance_after":17442,"derivative":{"exercise_price":16.15,"expiration_date":"2028-06-05","underlying":"Ordinary Shares","underlying_shares":17442},"source":{"system":"sec-edgar","filing":"0001104659-18-039246","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465918039246/a4.xml","form_type":"4"}},{"id":3900168,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-08T21:50:01.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":9290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities underlying restricted share units (\"RSUs\"). All securities will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events."}],"balance_after":9290,"source":{"system":"sec-edgar","filing":"0001104659-18-039246","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000110465918039246/a4.xml","form_type":"4"}},{"id":3899903,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2018-06-08T20:10:49.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":13000,"derivative":{"exercise_price":16.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-18-036661","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919118036661/doc4.xml","form_type":"4"}},{"id":3915655,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Shares","published_at":"2018-05-29T23:19:39.000Z","date":"2018-05-29","kind":"exercise","acquired":false,"shares":71967,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon closing of the Issuer's initial public offering, the preferred shares automatically converted into the Issuer's Class A Common Shares on a one-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Malley is the president of Mossrock Capital, LLC (\"Mossrock\") and may be deemed to beneficially own the shares owned by Mossrock."}],"balance_after":0,"derivative":{"underlying":"Class A Common Shares","underlying_shares":71967},"source":{"system":"sec-edgar","filing":"0001104659-18-036486","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036486/a4.xml","form_type":"4"}},{"id":3915654,"issuer":{"id":1954,"kind":"organization","name":"Kiniksa Pharmaceuticals International, plc","symbol":"KNSA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Shares","published_at":"2018-05-29T23:19:39.000Z","date":"2018-05-29","kind":"exercise","acquired":true,"shares":71967,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Malley is the president of Mossrock Capital, LLC (\"Mossrock\") and may be deemed to beneficially own the shares owned by Mossrock."}],"balance_after":71967,"source":{"system":"sec-edgar","filing":"0001104659-18-036486","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730430/000110465918036486/a4.xml","form_type":"4"}},{"id":4263972,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T23:11:08.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":7873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":204981,"source":{"system":"sec-edgar","filing":"0001179110-17-010097","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000117911017010097/edgar.xml","form_type":"4"}},{"id":4285448,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2017-06-12T21:52:24.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":8.6,"expiration_date":"2027-06-08","underlying":"Common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-039261","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422143/000120919117039261/doc4.xml","form_type":"4"}},{"id":4291292,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2017-06-06T20:18:38.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":169988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In ordinary shares.  Each American Depositary Share represents 13 Ordinary Shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"In ordinary shares.  Each American Depositary Share represents 13 Ordinary Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board or otherwise ceases to serve as a director, unless the Board determines otherwise."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"In ordinary shares.  Each American Depositary Share represents 13 Ordinary Shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"In ordinary shares.  Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":169988,"derivative":{"exercise_price":3.16,"expiration_date":"2027-06-01","underlying":"Ordinary Shares","underlying_shares":169988},"source":{"system":"sec-edgar","filing":"0001179110-17-008657","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911017008657/edgar.xml","form_type":"4"}},{"id":4360737,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-05T01:02:08.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":7085,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":197108,"source":{"system":"sec-edgar","filing":"0001179110-17-005740","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000117911017005740/edgar.xml","form_type":"4"}},{"id":4502335,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T01:30:28.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":8660,"price":1.53,"value":13249.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":190023,"source":{"system":"sec-edgar","filing":"0001179110-17-000420","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000117911017000420/edgar.xml","form_type":"4"}},{"id":4541156,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"American Depositary Shares","published_at":"2016-11-28T21:02:37.000Z","date":"2016-11-23","kind":"purchase","acquired":true,"shares":30000,"price":32,"value":960000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The purchase transaction reported on this Form 4 was effected as part of an underwritten public offering of Ordinary Shares in the form of American Depositary Shares of the Company."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001179110-16-032122","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1651308/000117911016032122/edgar.xml","form_type":"4"}},{"id":4586583,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":41320,"kind":"person","name":"Malley Thomas","position":1,"cik":"0001403322","reported_name":"Malley Thomas","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T21:11:26.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":1850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":181363,"source":{"system":"sec-edgar","filing":"0001179110-16-030317","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403322/000117911016030317/edgar.xml","form_type":"4"}}]}